|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.256 SEK | -0.95% |
|
-3.79% | -38.07% |
| 08/06 | Irlab shares trade ex-rights on Nasdaq Stockholm following rights issue | FW |
| 06/06 | IRLAB Therapeutics AB Announces Board Elections, Effective June 5, 2026 | CI |
| Market Cap | 108M 11.29M 9.79M 9.03M 8.46M 15.81M 1.08B 16.14M 41.7M 521M 42.37M 41.46M 1.81B | P/E Ratio 2025 * |
-
| P/E Ratio 2026 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 108M 11.29M 9.79M 9.03M 8.46M 15.81M 1.08B 16.14M 41.7M 521M 42.37M 41.46M 1.81B | EV / Sales 2025 |
2.91x | EV / Sales 2026 * | 1.06x |
| Free-Float |
38.17% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: IRLAB Therapeutics AB
| 1 day | -3.79% | ||
| 1 week | -3.79% | ||
| Current month | -0.16% | ||
| 1 month | -1.93% | ||
| 3 months | -22.78% | ||
| 6 months | -37.11% | ||
| Current year | -38.07% |
| 1 week | 1.19 |  | 1.27 |
| 1 month | 1.19 | | 1.32 |
| Current year | 1.17 | | 2.14 |
| 1 year | 1.17 | | 7.27 |
| 3 years | 1.17 | | 20.2 |
| 5 years | 1.17 | | 81.8 |
| 10 years | 1.17 | | 110 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 01/08/2024 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 01/01/2013 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 01/01/2016 |
| Chairman | 73 | 07/05/2020 | |
| Chairman | 68 | 20/02/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/07/25 | Buy | Chairman | 36,000 | 45.1264% | ||
| 27/07/25 | Buy | Chief Executive Officer | 75,589 | 94.7516% | ||
| 18/07/25 | Buy | Chief Technology Officer | 357,327 | 447.9129% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.95% | -3.79% | -82.32% | -84.83% | 11.29M | |
| +2.16% | +3.17% | +43.57% | +160.28% | 1,035B | |
| -0.07% | +4.45% | +53.50% | +48.95% | 574B | |
| -0.08% | -0.08% | +17.37% | +62.66% | 397B | |
| +0.15% | +0.77% | +21.19% | +15.95% | 324B | |
| +1.36% | -1.01% | +24.37% | +15.96% | 281B | |
| +0.92% | +3.81% | +24.89% | +34.83% | 278B | |
| +0.88% | +4.82% | -45.09% | -47.88% | 193B | |
| +4.84% | +2.45% | +21.33% | +61.85% | 191B | |
| +3.61% | -2.56% | +15.16% | +61.12% | 156B | |
| Average | +1.04% | +1.76% | +9.40% | +32.89% | 342.99B | |
| Weighted average by Cap. | +1.35% | +2.39% | +29.47% | +72.99% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 56.3M 5.9M 5.12M 4.72M 4.42M 8.26M 565M 8.43M 21.8M 272M 22.15M 21.67M 947M | 102M 10.69M 9.28M 8.55M 8.01M 14.97M 1.02B 15.28M 39.49M 493M 40.13M 39.26M 1.72B |
| Net income | -110M -11.5M -9.98M -9.2M -8.62M -16.1M -1.1B -16.44M -42.47M -531M -43.16M -42.23M -1.84B | -32.6M -3.42M -2.96M -2.73M -2.56M -4.78M -327M -4.88M -12.62M -158M -12.83M -12.55M -548M |
| Net Debt | - | - |
Employees
31
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/06/26 | 1.256 kr | -0.95% | 20,994 |
| 11/06/26 | 1.268 kr | +2.42% | 248,809 |
| 10/06/26 | 1.238 kr | -0.16% | 68,834 |
| 09/06/26 | 1.240 kr | 0.00% | 92,260 |
| 08/06/26 | 1.240 kr | -2.21% | 34,661 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IRLAB A Stock
Select your edition
All financial news and data tailored to specific country editions
